-
1
-
-
0038690424
-
Trends in prevalence, awareness, treatment and control of hypertension in the United States, 1988-2000
-
Hajjar I., and Kotchen T.A. Trends in prevalence, awareness, treatment and control of hypertension in the United States, 1988-2000. J Am Med Assoc 290 (2003) 199-206
-
(2003)
J Am Med Assoc
, vol.290
, pp. 199-206
-
-
Hajjar, I.1
Kotchen, T.A.2
-
2
-
-
0034685403
-
Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
ALLHAT Collaborative Research Group
-
ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Am Med Assoc 283 (2000) 1967-1975
-
(2000)
J Am Med Assoc
, vol.283
, pp. 1967-1975
-
-
-
3
-
-
0038460302
-
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report
-
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J Am Med Assoc 289 (2003) 2560-2572
-
(2003)
J Am Med Assoc
, vol.289
, pp. 2560-2572
-
-
-
4
-
-
27744521683
-
-
March 27
-
Federal Register 40 60 (1975) 13496 March 27
-
(1975)
Federal Register
, vol.40
, Issue.60
, pp. 13496
-
-
-
5
-
-
0025210469
-
A comparison of a controlled release (CR/ZOK) formulation of metoprolol, once daily, with conventional metoprolol tablets, twice daily, in mild to moderate hypertension
-
Carruthers G., Shearer R., Taylor W., and Moore M. A comparison of a controlled release (CR/ZOK) formulation of metoprolol, once daily, with conventional metoprolol tablets, twice daily, in mild to moderate hypertension. J Clin Pharmacol 30 Suppl 2 (1990) S61-S66
-
(1990)
J Clin Pharmacol
, vol.30
, Issue.SUPPL. 2
-
-
Carruthers, G.1
Shearer, R.2
Taylor, W.3
Moore, M.4
-
6
-
-
0036436746
-
Metoprolol succinate SR plus hydrochlorothiazide (Beloc-Zok Comp) in patients with essential hypertension in general practice. A prospective, observational trial in 19,964 patients
-
Hildemann S.K., Fischer H., Pittrow D., and Bohlsheid V. Metoprolol succinate SR plus hydrochlorothiazide (Beloc-Zok Comp) in patients with essential hypertension in general practice. A prospective, observational trial in 19,964 patients. Clin Drug Invest 22 (2002) 719-729
-
(2002)
Clin Drug Invest
, vol.22
, pp. 719-729
-
-
Hildemann, S.K.1
Fischer, H.2
Pittrow, D.3
Bohlsheid, V.4
-
7
-
-
0242654867
-
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
-
Blood Pressure Lowering Treatment Trialists' Collaboration
-
Turnbull F., and Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 362 (2003) 1527-1535
-
(2003)
Lancet
, vol.362
, pp. 1527-1535
-
-
Turnbull, F.1
-
8
-
-
0038312287
-
Health outcomes associated with the various antihypertensive therapies used as first-line agents
-
Psaty B.M., Lumley T., Furberg C., Schellenbaum G., Pahor M., Alderman M.H., and Weiss H.S. Health outcomes associated with the various antihypertensive therapies used as first-line agents. J Am Med Assoc 289 (2003) 2534-2544
-
(2003)
J Am Med Assoc
, vol.289
, pp. 2534-2544
-
-
Psaty, B.M.1
Lumley, T.2
Furberg, C.3
Schellenbaum, G.4
Pahor, M.5
Alderman, M.H.6
Weiss, H.S.7
-
9
-
-
0033589756
-
Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study
-
Hansson L., Lindholm L.H., Ekbom T., Dahlöf B., Lanke J., Schersten B., Wester P.O., Hedner T., and de Faire U. Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study. Lancet 354 (1999) 1751-1756
-
(1999)
Lancet
, vol.354
, pp. 1751-1756
-
-
Hansson, L.1
Lindholm, L.H.2
Ekbom, T.3
Dahlöf, B.4
Lanke, J.5
Schersten, B.6
Wester, P.O.7
Hedner, T.8
de Faire, U.9
-
10
-
-
0025942936
-
Morbity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension)
-
Dahlöf B., Lindholm L.H., Hansson L., Schersten B., Ekbrom T., and Wester P.O. Morbity and mortality in the Swedish trial in old patients with hypertension (STOP-Hypertension). Lancet 338 (1991) 1281-1285
-
(1991)
Lancet
, vol.338
, pp. 1281-1285
-
-
Dahlöf, B.1
Lindholm, L.H.2
Hansson, L.3
Schersten, B.4
Ekbrom, T.5
Wester, P.O.6
-
11
-
-
0034734389
-
Evaluation of a combination drug with multiple doses in unbalanced factorial design clinical trials
-
Hung H.M.J. Evaluation of a combination drug with multiple doses in unbalanced factorial design clinical trials. Stat Med 19 (2000) 2079-2087
-
(2000)
Stat Med
, vol.19
, pp. 2079-2087
-
-
Hung, H.M.J.1
-
12
-
-
0026600436
-
On identifying a positive dose-response surface for combination agents
-
Hung H.M.J. On identifying a positive dose-response surface for combination agents. Stat Med 11 (1992) 703-711
-
(1992)
Stat Med
, vol.11
, pp. 703-711
-
-
Hung, H.M.J.1
-
13
-
-
33845219878
-
-
SAS release 8.2. Users guide. Cary, NC: SAS Institute.
-
-
-
-
14
-
-
33645000530
-
Antihypertensive medication use among adults with hypertension
-
Gu Q., Paulose-Ram R., Dillion C., and Burnt V. Antihypertensive medication use among adults with hypertension. Circulation 113 (2006) 213-221
-
(2006)
Circulation
, vol.113
, pp. 213-221
-
-
Gu, Q.1
Paulose-Ram, R.2
Dillion, C.3
Burnt, V.4
-
15
-
-
33845191828
-
-
Hydrodiuril. Product label. West Point, PA: Merck & Co.
-
-
-
-
16
-
-
33845220664
-
-
Toprol-XL. Product label AstraZeneca LP, Wilmington, DE, www.Toprol-XL.com
-
-
-
-
17
-
-
0842264858
-
Continued importance of diuretics and β-adrenergic blockers in the management of hypertension
-
Moser M., and Setaro J. Continued importance of diuretics and β-adrenergic blockers in the management of hypertension. Med Clin North Am 88 (2004) 167-187
-
(2004)
Med Clin North Am
, vol.88
, pp. 167-187
-
-
Moser, M.1
Setaro, J.2
|